Nine Names
Full reviewer path
This page holds the deeper audit modules. Contact stays at the bottom.
Identify the claim, decision context, and what would make it useful or unsafe.
Track datasets, tissue, platform, access, metadata, and missing artifacts.
Treat QC filters, normalization anchors, and matrix construction as testable choices.
Separate cell-level signals from donor-level and cross-cohort support.
Ask whether the signal is disease, age, assay, stage, selection, or artifact.
Publish only public-safe summaries; controlled material waits for qualified review.
Recent examples
Each example shows a public-safe verdict and inspection rows; dense source tables wait for qualified review.
Overstrong claims get held, narrowed, or routed to qualified review before publication.
Claims without source-checked backing stay request-only or held.
Medical decisions stay with physicians, PIs, and qualified reviewers.
Evidence snapshot
What we actually did
A claim moves only after sources, defaults, donor/cohort support, and failure modes are checked. The figures show the public-safe shape of that inspection.
Audit method
Each row names the check, the failure mode, and the output we expect before public language gets sharper.
Full source tables are request-only; the public page shows the audit shape.
Audit outcomes
The narrow claim survived source, method, and donor/cohort checks.
The signal is useful, but limited by cohort, assay, metadata, or review access.
The material stays off the public page until source checks and safety checks pass.
The claim was too broad, too clinical, or too strong for the evidence.
Boundaries
Clinical decisions stay with physicians and PIs. No prescriptions, recruitment, or treatment instructions.
Contact
Send role, claim, and source question. Do not send patient files or treatment requests.